Spoken Alpha
TELA Bio, Inc.
TELA Bio designs and commercializes reinforced tissue matrices for soft-tissue reconstruction in hernia repair and plastic/reconstructive surgery.
TELA Bio, Inc is a Healthcare company operating in Medical Devices with a $44.1M market cap.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add TELA, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TELA.
$ curl https://api.spokenalpha.com/v1/companies/TELAFAQ
Spoken Alpha indexes TELA's earnings call transcripts at https://spokenalpha.com/companies/TELA. Each call links to attributed speakers and parsed analyst Q&A. TELA Bio, Inc.'s own investor relations page is at https://ir.telabio.com/.
TELA Bio, Inc. (TELA) operates in the Healthcare sector (Medical Devices industry).